Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sofinnova
Podcast
A closer look at European biotech investment in 2024
This week on “The Top Line,” we explore the European biotech investment landscape.
Ayla Ellison
,
James Waldron
Mar 22, 2024 8:43am
GLP-1 enthusiasm pushes BioAge into new age with $170M series D
Feb 13, 2024 8:00am
Sofinnova opens biotech creation ‘toolbox’ for Europe strategy
Dec 13, 2023 9:20am
Optimism at Jefferies, but don't expect IPO boost soon—Sofinnova
Nov 16, 2023 3:00am
Investors shower Star Therapeutics with $90M series C
Sep 5, 2023 7:00am
Moon Surgical raises $55M, taps Fred Moll as board chair
May 17, 2023 1:24pm